<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="generate">
            <roleset id="generate.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="agent, causer&#x09;&#x09;//gene, process//&#x0A;" />
                    <role n="1" descr="thing created&#x09;&#x09;&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A transcription start site is located approximately 4 kilobases 5 to the translation codon, and an RNA splice of 3863 bases occurring in the 5-untranslated region generates mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>Abeta peptides can be generated from proteolysis of the amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that L723 in H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of degradation, although again the relatively small fraction involved and the possibility that specific fragments are not generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Major transcripts of 1.7 and 2.7 kb are generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Major transcripts of 1.7 and 2.7 kb were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Prnd generated major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Prnd generated major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generated a DNase I hypersensitive.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>proteolysis of the amyloid precursor proteins (APP) generated Abeta peptides.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>some unusual chimeric transcripts were generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>some unusual chimeric transcripts will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="GREC" no="1">
                    <text>We report results from preliminary transcription microarray experiments that revealed two previously unknown members of the NarL regulon: the aspA gene encoding aspartate-ammonia lyase, which generates fumarate; and the dcuSR operon encoding the dicarboxylate-responsive regulatory system.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="MEDLINE" no="1">
                    <text>Prnd generates major transcripts of 1.7 and 2.7 kb as well as some unusual chimeric transcripts generated by intergenic splicing with Prnp.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that Abeta peptides was generated by proteolysis of the amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that Prnd generates major transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that a higher order protein-DNA complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that a monoclonal antibody against FHL2 will be generated by we.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that fumarase B is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating fumarate.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that fumarate has been generated by fumarase B</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that fumarate will be generated by fumarase B.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that major transcripts of 1.7 and 2.7 kb will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that sequential overlapping fragments was generated by The TBC method.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that the 21-23 nt long mature RNAs is generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that we generated a monoclonal antibody against FHL2.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that we generates a monoclonal antibody against FHL2.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) can generate a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generates a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) is able to generate a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of L723 in H3, although again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface will not be generated by degradation.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of NO reacts anaerobically with the Fe-S cluster of purified FNR, although again the relatively small fraction involved and the possibility that degradation did not generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex or occured rapidly precludes any definitive conclusions</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of The bidentate RNase III Dicer, although again the relatively small fraction involved and the possibility that the 21-23 nt long mature RNAs will not be generated by degradation.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of fumarase B, although again the relatively small fraction involved and the possibility that fumarate are not generated by degradation.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of fumarase B, although again the relatively small fraction involved and the possibility that fumarate have not been generated by degradation.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of this binding, although again the relatively small fraction involved and the possibility that a higher order protein-DNA complex were not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of this binding, although again the relatively small fraction involved and the possibility that a higher order protein-DNA complex were not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of us, although again the relatively small fraction involved and the possibility that degradation did not generate a monoclonal antibody against FHL2 or occured rapidly precludes any definitive conclusions</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that degradation does not generate a monoclonal antibody against FHL2 or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>In the absence of L-arginine, The bidentate RNase III Dicer generated the 21-23 nt long mature RNAs (O(2)-).</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>In the absence of L-arginine, a higher order protein-DNA complex (O(2)-) is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>In the absence of L-arginine, degradation generates specific fragments (O(2)-).</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) is generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>L723 in H3 generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>L723 in H3 has generated the correct three-dimensional interaction surface ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>L723 in H3 is able to generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>L723 in H3 may generate the correct three-dimensional interaction surface ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>L723 in H3 may generate the correct three-dimensional interaction surface ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>Major transcripts of 1.7 and 2.7 kb are generated by NO reacts anaerobically with the Fe-S cluster of purified FNR.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>Major transcripts of 1.7 and 2.7 kb are generated by fumarase B.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>Major transcripts of 1.7 and 2.7 kb were generated by NO reacts anaerobically with the Fe-S cluster of purified FNR.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>NO reacts anaerobically with the Fe-S cluster of purified FNR may generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>NO reacts anaerobically with the Fe-S cluster of purified FNR was optimized to generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>Prnd generated major transcripts of 1.7 and 2.7 kb ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Prnd generates major transcripts of 1.7 and 2.7 kb within the recombinational synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>Sequential overlapping fragments are generated by degradation ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>Sequential overlapping fragments were generated by Prnd ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>The TBC method can generate sequential overlapping fragments.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>The TBC method generated sequential overlapping fragments within the recombinational synapse.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>The TBC method generates sequential overlapping fragments.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>The TBC method, generating sequential overlapping fragments.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>The bidentate RNase III Dicer generated the 21-23 nt long mature RNAs within the recombinational synapse.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>The bidentate RNase III Dicer may generate the 21-23 nt long mature RNAs ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>These are Abeta peptides reductase (encoded by the frdABCD operon), proteolysis of the amyloid precursor proteins (APP), which will generate fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">proteolysis of the amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>These are major transcripts of 1.7 and 2.7 kb reductase (encoded by the frdABCD operon), Prnd, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>These are major transcripts of 1.7 and 2.7 kb reductase (encoded by the frdABCD operon), Prnd, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>These are sequential overlapping fragments reductase (encoded by the frdABCD operon), The TBC method, which generates fumarate from malate, and the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>These are specific fragments reductase (encoded by the frdABCD operon), degradation, which generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>These are the correct three-dimensional interaction surface reductase (encoded by the frdABCD operon), L723 in H3, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>To analyse specifically protein expression of FHL2 in human tissues a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) may generate a DNase I hypersensitive.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generate a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) generate a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, NO reacts anaerobically with the Fe-S cluster of purified FNR generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, degradation will generate specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, fumarate was generated by fumarase B</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, major transcripts of 1.7 and 2.7 kb was generated by Prnd</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, superoxide is generated by nNOS</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, the 21-23 nt long mature RNAs was generated by The bidentate RNase III Dicer</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>We believe L723 in H3 is found to generate the correct three-dimensional interaction surface within the recombinational synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>We believe NO reacts anaerobically with the Fe-S cluster of purified FNR is shown to generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex within the recombinational synapse.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>We believe NO reacts anaerobically with the Fe-S cluster of purified FNR is shown to generate spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex within the recombinational synapse.</text>
                    <arg n="0">NO reacts anaerobically with the Fe-S cluster of purified FNR</arg>
                    <arg n="1">spectral changes consistent with formation of a dinitrosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>We believe Prnd is found to generate major transcripts of 1.7 and 2.7 kb within the recombinational synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>We believe The TBC method is required to generate sequential overlapping fragments within the recombinational synapse.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>We believe degradation is found to generate specific fragments within the recombinational synapse.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>We believe us is shown to generate a monoclonal antibody against FHL2 within the recombinational synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>We believe we is shown to generate a monoclonal antibody against FHL2 within the recombinational synapse.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>We show that nNOS, to generate superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro (from malate, and the DcuB permease for fumarate, malate, and aspartate) were generated by EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1).</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro are generated from EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) by beta- and gamma-secretases.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro can be generated from EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) by beta- and gamma-secretases.</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro is generated by EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1).</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro were generated by EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1).</text>
                    <arg n="0">EKLF requires a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive, transcriptionally active beta-globin promoter on chromatin templates in vitro</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) cleaves microRNA precursors to generate a DNase I hypersensitive.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1) has generated a DNase I hypersensitive.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF coactivator-remodeling complex 1 (E-RC1)</arg>
                    <arg n="1">a DNase I hypersensitive</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>a higher order protein-DNA complex (from malate, and the DcuB permease for fumarate, malate, and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>a higher order protein-DNA complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>a monoclonal antibody against FHL2 have been generated from us by beta- and gamma-secretases.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>a monoclonal antibody against FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>degradation generated specific fragments ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>fumarase B generated fumarate within the recombinational synapse.</text>
                    <arg n="0">fumarase B</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>nNOS has generated superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>nNOS was optimized to generate superoxide ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>sequential overlapping fragments (from malate, and the DcuB permease for fumarate, malate, and aspartate) are generated by The TBC method.</text>
                    <arg n="0">The TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>specific fragments are generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>specific fragments is generated by degradation within the recombinational synapse.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>specific fragments were generated from degradation by beta- and gamma-secretases.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>superoxide is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>superoxide is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>the 21-23 nt long mature RNAs (from malate, and the DcuB permease for fumarate, malate, and aspartate) were generated by The bidentate RNase III Dicer.</text>
                    <arg n="0">The bidentate RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>this binding cleaves microRNA precursors to generate a higher order protein-DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>this binding cleaves microRNA precursors to generate a higher order protein-DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>this binding was optimized to generate a higher order protein-DNA complex ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>this binding was optimized to generate a higher order protein-DNA complex ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>this binding was optimized to generate a higher order protein-DNA complex ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>us generated a monoclonal antibody against FHL2 ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>us generates a monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>we can generate a monoclonal antibody against FHL2.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>we generated a monoclonal antibody against FHL2 ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>we generates a monoclonal antibody against FHL2 ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a monoclonal antibody against FHL2</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that The DNA-binding mutant (Stat5aEE-AA) of Stat5a will be generated by mutating amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that a functional interaction surface has been generated by the AR N-terminus</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that a functional interaction surface is generated by the AR N-terminus.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that an alternative splicing of the primary transcript of the gene is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating Human leukocyte antigen (HLA)-G molecules.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that intergenic splicing with Prnp generated some unusual chimeric transcripts.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that mature HeLa cell mRNA was generated by an RNA splice of 3863 bases occurs in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that mature HeLa cell mRNA will be generated by an RNA splice of 3863 bases occurs in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that the AR N-terminus generated a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Although no crystal structure of the AR is available to date, one might speculate that the AR N-terminus is either directly involved in the AR-FHL2 interaction or, alternatively, is essential for generating a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Human leukocyte antigen (HLA)-G molecules was generated by an alternative splicing of the primary transcript of the gene within the recombinational synapse.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>In addition, there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that degradation did not generate Human leukocyte antigen (HLA)-G molecules or occured rapidly precludes any definitive conclusions</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>In addition, there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that degradation does not generate Human leukocyte antigen (HLA)-G molecules or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>In addition, there was an apparent absence of lointergenic splicing with Prnpr molecular weight fragments as evidence of we, although again the relatively small fraction involved and the possibility that some unusual chimeric transcripts will not be generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene, although again the relatively small fraction involved and the possibility that Human leukocyte antigen (HLA)-G molecules are not generated by degradation.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of intergenic splicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual chimeric transcripts were not generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>In addition, there was an apparent absence of lower molecular weight fragments as evidence of mutating amino acids EE (437 and 438) to AA, although again the relatively small fraction involved and the possibility that degradation does not generate The DNA-binding mutant (Stat5aEE-AA) of Stat5a or occurs rapidly precludes any definitive conclusions.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>In the absence of L-arginine, Human leukocyte antigen (HLA)-G molecules (O(2)-) is generated by an alternative splicing of the primary transcript of the gene.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>In the absence of L-arginine, The DNA-binding mutant (Stat5aEE-AA) of Stat5a (O(2)-) has been generated by mutating amino acids EE (437 and 438) to AA.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>In the absence of L-arginine, an RNA splice of 3863 bases occurs in the 5-untranslated region generates mature HeLa cell mRNA (O(2)-).</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>In the absence of L-arginine, an alternative splicing of the primary transcript of the gene generated Human leukocyte antigen (HLA)-G molecules (O(2)-).</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>In the absence of L-arginine, an alternative splicing of the primary transcript of the gene generates Human leukocyte antigen (HLA)-G molecules (O(2)-).</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>In the absence of L-arginine, fumarate (O(2)-) was generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>In the absence of L-arginine, mature HeLa cell mRNA (O(2)-) will be generated by an RNA splice of 3863 bases occurring in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>In the absence of L-arginine, some unusual chimeric transcripts (O(2)-) has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Major transcripts of 1.7 and 2.7 kb an RNA splice of 3863 bases occurs in the 5-untranslated regionre generated by we.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Major transcripts of 1.7 and 2.7 kb an RNA splice of 3863 bases occurs in the 5-untranslated regionre generated by we.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Major transcripts of 1.7 and 2.7 kb an alternative splicing of the primary transcript of the genere generated by we.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Major transcripts of 1.7 and 2.7 kb are generated by an RNA splice of 3863 bases occurs in the 5-untranslated region.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Major transcripts of 1.7 and 2.7 kb are generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Sequential overlapping fragments are generated by an RNA splice of 3863 bases occurs in the 5-untranslated region ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">an RNA splice of 3863 bases occurs in the 5-untranslated region</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Sequential overlapping fragments are generated by intergenic splicing with Prnp ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Sequential overlapping fragments were generated by aspartate-ammonia lyase ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>The DNA-binding mutant (Stat5aEE-AA) of Stat5a mutating amino acids EE (437 and 438) to AAre generated by we.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>These are Human leukocyte antigen (HLA)-G molecules reductase (encoded by the frdABCD operon), an alternative splicing of the primary transcript of the gene, which generates fumarate from malate, and the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>These are Human leukocyte antigen (HLA)-G molecules reductase (encoded by the frdABCD operon), an alternative splicing of the primary transcript of the gene, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>These are The DNA-binding mutant (Stat5aEE-AA) of Stat5a reductase (encoded by the frdABCD operon), mutating amino acids EE (437 and 438) to AA, which will generate fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>These are fumarate reductase (encoded by the frdABCD operon), aspartate-ammonia lyase, which will generate fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>These are mature HeLa cell mRNA reductase (encoded by the frdABCD operon), an RNA splice of 3863 bases occurring in the 5-untranslated region, which generates fumarate from malate, and the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>These are some unusual chimeric transcripts reductase (encoded by the frdABCD operon), intergenic splicing with Prnp, which have generated fumarate from malate, the DcuB permease for fumarate, malate, and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>To analyse specifically protein expression of FHL2 in human tissues intergenic splicing with Prnp generated some unusual chimeric transcripts.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, a functional interaction surface is generated by the AR N-terminus</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, a functional interaction surface was generated by the AR N-terminus</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, an RNA splice of 3863 bases occurring in the 5-untranslated region generate mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, an RNA splice of 3863 bases occurring in the 5-untranslated region generate mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, some unusual chimeric transcripts is generated by intergenic splicing with Prnp</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>To analyse specifically protein expression of FHL2 in human tissues, the AR N-terminus will generate a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>We believe an RNA splice of 3863 bases occurring in the 5-untranslated region is found to generate mature HeLa cell mRNA within the recombinational synapse.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>We believe an alternative splicing of the primary transcript of the gene is required to generate Human leukocyte antigen (HLA)-G molecules within the recombinational synapse.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>We believe an alternative splicing of the primary transcript of the gene is shown to generate Human leukocyte antigen (HLA)-G molecules within the recombinational synapse.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>We believe aspartate-ammonia lyase is required to generate fumarate within the recombinational synapse.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>We believe aspartate-ammonia lyase is shown to generate fumarate within the recombinational synapse.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>We show that an RNA splice of 3863 bases occurring in the 5-untranslated region, to generate mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>a functional interaction surface were generated from the AR N-terminus by beta- and gamma-secretases.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>an RNA splice of 3863 bases occurring in the 5-untranslated region generated mature HeLa cell mRNA within the recombinational synapse.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>an RNA splice of 3863 bases occurring in the 5-untranslated region is able to generate mature HeLa cell mRNA.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>an RNA splice of 3863 bases occurring in the 5-untranslated region may generate mature HeLa cell mRNA ( approximately 0.4-0.5 kb ) for each of the gene sequences, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of PCR conditions.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>an alternative splicing of the primary transcript of the gene, generating Human leukocyte antigen (HLA)-G molecules.</text>
                    <arg n="0">an alternative splicing of the primary transcript of the gene</arg>
                    <arg n="1">Human leukocyte antigen (HLA)-G molecules</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>aspartate-ammonia lyase generates fumarate within the recombinational synapse.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumarate</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>intergenic splicing with Prnp generated some unusual chimeric transcripts.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>intergenic splicing with Prnp, generating some unusual chimeric transcripts.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>intergenic splicing with Prnp, generating some unusual chimeric transcripts.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcripts</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>major transcripts of 1.7 and 2.7 kb Prndre generated from we by beta- and gamma-secretases.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">major transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>mature HeLa cell mRNA an RNA splice of 3863 bases occurring in the 5-untranslated regionre generated from we by beta- and gamma-secretases.</text>
                    <arg n="0">an RNA splice of 3863 bases occurring in the 5-untranslated region</arg>
                    <arg n="1">mature HeLa cell mRNA</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>mutating amino acids EE (437 and 438) to AA generated The DNA-binding mutant (Stat5aEE-AA) of Stat5a within the recombinational synapse.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>mutating amino acids EE (437 and 438) to AA generates The DNA-binding mutant (Stat5aEE-AA) of Stat5a within the recombinational synapse.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>mutating amino acids EE (437 and 438) to AA has generated The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mutating amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">The DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>the AR N-terminus cleaves microRNA precursors to generate a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>the AR N-terminus, generating a functional interaction surface.</text>
                    <arg n="0">the AR N-terminus</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
